Literature DB >> 32356479

Peripherally inserted central catheters inserted with current best practices have low deep vein thrombosis and central line-associated bloodstream infection risk compared with centrally inserted central catheters: A contemporary meta-analysis.

Gregory J Schears1, Nicole Ferko2, Imran Syed2, John-Michael Arpino2, Kimberly Alsbrooks3.   

Abstract

BACKGROUND: Peripherally inserted central catheters and centrally inserted central catheters have numerous benefits but can be associated with risks. This meta-analysis compared central catheters for relevant clinical outcomes using recent studies more likely to coincide with practice guidelines.
METHODS: Several databases, Ovid MEDLINE, Embase, and EBM Reviews were searched for articles (2006-2018) that compared central catheters. Analyses were limited to peer-reviewed studies comparing peripherally inserted central catheters to centrally inserted central catheters for deep vein thrombosis and/or central line-associated bloodstream infections. Subgroup, sensitivity analyses, and patient-reported measures were included. Risk ratios, incidence rate ratios, and weighted event risks were reported. Study quality assessment was conducted using Newcastle-Ottawa and Cochrane Risk of Bias scales.
RESULTS: Of 4609 screened abstracts, 31 studies were included in these meta-analyses. Across studies, peripherally inserted central catheters were protective for central line-associated bloodstream infection (incidence rate ratio = 0.52, 95% confidence interval: 0.30-0.92), with consistent results across subgroups. Peripherally inserted central catheters were associated with an increased risk of deep vein thrombosis (risk ratio = 2.08, 95% confidence interval: 1.47-2.94); however, smaller diameter and single-lumen peripherally inserted central catheters were no longer associated with increased risk. The absolute risk of deep vein thrombosis was calculated to 2.3% and 3.9% for smaller diameter peripherally inserted central catheters and centrally inserted central catheters, respectively. On average, peripherally inserted central catheter patients had 11.6 more catheter days than centrally inserted central catheter patients (p = 0.064). Patient outcomes favored peripherally inserted central catheters.
CONCLUSION: When adhering to best practices, this study demonstrated that concerns related to peripherally inserted central catheters and deep vein thrombosis risk are minimized. Dramatic changes to clinical practice over the last 10 years have helped to address past issues with central catheters and complication risk. Given the lower rate of complications when following current guidelines, clinicians should prioritize central line choice based on patient therapeutic needs, rather than fear of complications. Future research should continue to consider contemporary literature over antiquated data, such that it recognizes the implications of best practices in modern central catheterization.

Entities:  

Keywords:  Peripherally inserted central catheters; catheter; catheter days; central line–associated bloodstream infection; centrally inserted central catheters; deep vein thrombosis; meta-analysis

Mesh:

Year:  2020        PMID: 32356479     DOI: 10.1177/1129729820916113

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  5 in total

1.  Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis.

Authors:  Yosuke Nakaya; Mika Imasaki; Michinori Shirano; Katsujun Shimizu; Naoko Yagi; Minako Tsutsumi; Masahiro Yoshida; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Takahisa Yamane
Journal:  Ann Hematol       Date:  2022-07-02       Impact factor: 4.030

2.  Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care.

Authors:  Juan Carlos Laguna; Tim Cooksley; Shin Ahn; Nikolaos Tsoukalas; Thein Hlaing Oo; Norman Brito-Dellan; Francis Esposito; Carmen Escalante; Carme Font
Journal:  Support Care Cancer       Date:  2022-08-06       Impact factor: 3.359

3.  A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies.

Authors:  Jing Yue; Ya Zhang; Fang Xu; Ai Mi; Qiaolin Zhou; Bin Chen; Lin Shi
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

4.  Patterns, appropriateness and outcomes of peripherally inserted central catheter use in Brazil: a multicentre study of 12 725 catheters.

Authors:  Eneida Rejane Rabelo-Silva; Solange Antonia Lourenço; Rubia Natasha Maestri; Claudia Candido da Luz; Vanderlei Carlos Pupin; Raquel Bauer Cechinel; Eduarda Bordini Ferro; Marco Aurélio Lumertz Saffi; Telma Christina do Campo Silva; Larissa Martins de Andrade; Larissa Fernanda Sales Gomes; Lorena Alves da Gama; Mariana Marques de Araújo; Fábio Rodrigues Ferreira do Espírito Santo; Leticia López Pedraza; Vânia Naomi Hirakata; Vilma Santana Soares; Widlani Sousa Montenegro; Gustavo Rocha Costa de Freitas; Thaís Souza de Jesus; Vineet Chopra
Journal:  BMJ Qual Saf       Date:  2022-01-27       Impact factor: 7.418

5.  Recommendations for the use of vascular access in the COVID-19 patients: an Italian perspective.

Authors:  Mauro Pittiruti; Fulvio Pinelli
Journal:  Crit Care       Date:  2020-05-28       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.